Getty Images (NYSE:GETY – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in ...

Fintel reports that on March 14, 2025, Wedbush upgraded their outlook for National CineMedia (NasdaqGS:NCMI) from Neutral to ...

Wedbush reissued their outperform rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a report issued on Wednesday morning, Marketbeat Ratings reports. They currently have a $8.00 ...

In-theater advertising company National CineMedia Inc. is well-positioned to reap the benefits of cinema’s unique proposition ...

Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth in the second ...

Wedbush raised the firm’s price target on Rubrik (RBRK) to $80 from $75 and keeps an Outperform rating on the shares. The firm notes Rubrik ...

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Just days after saying Tesla Inc.’s recent stock selloff was overdone, Wedbush analyst Dan Ives, a well-known tech analyst and Tesla bull, is taking a different approach: He’s speaking to the ...